Literature DB >> 23389614

Harnessing CD4⁺ T cell responses in HIV vaccine development.

Hendrik Streeck1, M Patricia D'Souza, Dan R Littman, Shane Crotty.   

Abstract

CD4(+) T cells can perform a panoply of tasks to shape an effective response against a pathogen. Limited attention has been paid to the potential importance of functional CD4(+) T cell responses in the context of the development of next-generation vaccines, including HIV vaccines. Many CD4(+) T cell functions are newly appreciated and only partially understood. A workshop was held as a forum to bring together a small group of experts to exchange ideas on the role of CD4(+) T cells in developing durable functional antibody responses, via follicular helper T cells, as well as on the roles of CD4(+) T cells in other aspects of protective immunity. Here we discuss whether CD4(+) T cell responses may represent a beneficial component of an efficacious HIV vaccine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389614      PMCID: PMC3626561          DOI: 10.1038/nm.3054

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  98 in total

1.  Cutting edge: induction of follicular homing precedes effector Th cell development.

Authors:  P Schaerli; P Loetscher; B Moser
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

2.  B cells acquire antigen from target cells after synapse formation.

Authors:  F D Batista; D Iber; M S Neuberger
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

3.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

4.  T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells.

Authors:  Tatyana Chtanova; Stuart G Tangye; Rebecca Newton; Nita Frank; Martin R Hodge; Michael S Rolph; Charles R Mackay
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

5.  HIV preferentially infects HIV-specific CD4+ T cells.

Authors:  Daniel C Douek; Jason M Brenchley; Michael R Betts; David R Ambrozak; Brenna J Hill; Yukari Okamoto; Joseph P Casazza; Janaki Kuruppu; Kevin Kunstman; Steven Wolinsky; Zvi Grossman; Mark Dybul; Annette Oxenius; David A Price; Mark Connors; Richard A Koup
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

6.  B cells extract and present immobilized antigen: implications for affinity discrimination.

Authors:  F D Batista; M S Neuberger
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

Review 7.  Immunological memory in humans.

Authors:  Shane Crotty; Rafi Ahmed
Journal:  Semin Immunol       Date:  2004-06       Impact factor: 11.130

8.  Determinants of release rate of tetanus vaccine from polyester microspheres.

Authors:  M J Alonso; S Cohen; T G Park; R K Gupta; G R Siber; R Langer
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

Review 9.  A Blueprint for HIV Vaccine Discovery.

Authors:  Dennis R Burton; Rafi Ahmed; Dan H Barouch; Salvatore T Butera; Shane Crotty; Adam Godzik; Daniel E Kaufmann; M Juliana McElrath; Michel C Nussenzweig; Bali Pulendran; Chris N Scanlan; William R Schief; Guido Silvestri; Hendrik Streeck; Bruce D Walker; Laura M Walker; Andrew B Ward; Ian A Wilson; Richard Wyatt
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

10.  A vaccine strategy that protects against genital herpes by establishing local memory T cells.

Authors:  Haina Shin; Akiko Iwasaki
Journal:  Nature       Date:  2012-10-17       Impact factor: 49.962

View more
  55 in total

Review 1.  Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form.

Authors:  David H Altreuter; Ameya R Kirtane; Tyler Grant; Cecilia Kruger; Giovanni Traverso; Andrew M Bellinger
Journal:  Expert Opin Drug Deliv       Date:  2018-11-13       Impact factor: 6.648

2.  Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine.

Authors:  Geert Leroux-Roels; Patricia Bourguignon; Julie Willekens; Michel Janssens; Frédéric Clement; Arnaud M Didierlaurent; Laurence Fissette; François Roman; Dominique Boutriau
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

Review 3.  HIV-1 vaccines: challenges and new perspectives.

Authors:  Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

Review 4.  C-type lectin receptors in the control of T helper cell differentiation.

Authors:  Teunis B H Geijtenbeek; Sonja I Gringhuis
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

5.  Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production.

Authors:  Patricio Oyarzún; Bostjan Kobe
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 6.  Early programming and late-acting checkpoints governing the development of CD4 T-cell memory.

Authors:  Kunal Dhume; Karl Kai McKinstry
Journal:  Immunology       Date:  2018-05-21       Impact factor: 7.397

7.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.

Authors:  Shilpi Verma; Daniela Weiskopf; Ankan Gupta; Bryan McDonald; Bjoern Peters; Alessandro Sette; Chris A Benedict
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features.

Authors:  Cecilia Lindestam Arlehamn; Gregory Seumois; Anna Gerasimova; Charlie Huang; Zheng Fu; Xiaojing Yue; Alessandro Sette; Pandurangan Vijayanand; Bjoern Peters
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

9.  HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses.

Authors:  Srinika Ranasinghe; Damien Z Soghoian; Madelene Lindqvist; Musie Ghebremichael; Faith Donaghey; Mary Carrington; Michael S Seaman; Daniel E Kaufmann; Bruce D Walker; Filippos Porichis
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

10.  Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation.

Authors:  Youn Soo Choi; Danelle Eto; Jessica A Yang; Christopher Lao; Shane Crotty
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.